Botulinum toxin treatment for chronic anal fissure
Record ID 32011000878
English
Authors' objectives:
Botulinum toxin (BTX) is used for the endoscopic treatment of gastrointestinal disorders such as chronic anal fissure (CAF) that are characterized by sphincteric spasticity. For the treatment of CAF, BTX is injected directly into the anal sphincter in order to produce chemical denervation by blocking synaptic transmission. This relaxes the sphincter, causes temporary relief of the symptoms, and allows healing.
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=11893
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Botulinum Toxins, Type A
- Chronic Disease
- Neuromuscular Agents
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.